Skoberne; Mojca

Patent Applications and Registrations

Patent applications and USPTO patent grants for Skoberne; Mojca.The latest application filed is for "antigen-binding proteins targeting shared antigens".

Company Profile

6.7.14

Skoberne; Mojca - Cambridge MA
Skoberne; Mojca - Emeryville CA
- Cambridge MA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antigen-binding Proteins Targeting Shared Antigens App 20220213196 - Jooss; Karin ; et al.	2022-07-07
Selection Of T Cell Receptors App 20220155321 - Davis; Matthew Joseph ; et al.	2022-05-19
Identification Of Neoantigens With Mhc Class Ii Model App 20220154281 - Boucher; Thomas Francis ; et al.	2022-05-19
Shared Antigens App 20210196806 - Yelensky; Roman ; et al.	2021-07-01
Antigen-binding Proteins Targeting Shared Antigens App 20210147550 - Jooss; Karin ; et al.	2021-05-20
Antigen-Binding Proteins Targeting Shared Antigens App 20210061914 - Jooss; Karin ; et al.	2021-03-04
Neoantigen Identification with Pan-Allele Models App 20200411135 - Boucher; Thomas Francis ; et al.	2020-12-31
Neoantigen Identification for T-Cell Therapy App 20200363414 - Yelensky; Roman ; et al.	2020-11-19
Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response Grant 10,653,771 - Long , et al.	2020-05-19
Vaccines Against Herpes Simplex Virus Type 2: Compositions And Methods For Eliciting An Immune Response App 20180369365 - Long; Deborah ; et al.	2018-12-27
Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response Grant 9,895,436 - Long , et al. February 20, 2	2018-02-20
Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response Grant 9,782,474 - Long , et al. October 10, 2	2017-10-10
Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response Grant 9,624,273 - Long , et al. April 18, 2	2017-04-18
Nucleic Acid Vaccines Against Herpes Simplex Virus Type 2: Compositions And Methods For Eliciting An Immune Response App 20140328870 - Long; Deborah ; et al.	2014-11-06
Vaccines Against Herpes Simplex Virus Type 2: Compositions And Methods For Eliciting An Immune Response App 20140227307 - Long; Deborah ; et al.	2014-08-14
Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response Grant 8,617,564 - Long , et al. December 31, 2	2013-12-31
Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response Grant 08617564 -	2013-12-31
Vaccines Against Herpes Simplex Virus Type 2: Compositions And Methods For Eliciting An Immune Response App 20130337000 - Long; Deborah ; et al.	2013-12-19
Vaccines Against Herpes Simplex Virus Type 2: Compositions And Methods For Eliciting An Immune Response App 20100330112 - Long; Deborah ; et al.	2010-12-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.